Furthermore, when GBM cells treated with pharmacological MTOR inhibitors (Rapamycin), the inhibition effect of LRRC4 on autophagy was broke, as the difference of p62 and LC3B protein level between vector and LRRC4-expressing group had no significant changes (Fig. 7e). The gene discussed is LRRC4; the disease is glioblastoma.